XML 61 R42.htm IDEA: XBRL DOCUMENT
v3.23.3

Schedule of Contractual Clinical Trials (Details) | 9 Months Ended
--- | ---
Sep. 30, 2023 Integer
Phase 1b [Member] |
Other Commitments [Line Items] |
Description of Clinical Trial | LB-100 combined with carboplatin, etoposide and atezolizumab in small cell lung cancer
Estimated Start Date | March 2021
Estimated End Date | March 2026
Phase 1b [Member] | Minimum [Member] |
Other Commitments [Line Items] |
Number of Patients in Trial | 14
Phase 1b [Member] | Maximum [Member] |
Other Commitments [Line Items] |
Number of Patients in Trial | 36
Phase 1b Two [Member] |
Other Commitments [Line Items] |
Description of Clinical Trial | LB-100 combined with doxorubicin in sarcoma
Estimated Start Date | June 2023
Estimated End Date | June 2024
Phase 1b Two [Member] | Minimum [Member] |
Other Commitments [Line Items] |
Number of Patients in Trial | 9
Phase 1b Two [Member] | Maximum [Member] |
Other Commitments [Line Items] |
Number of Patients in Trial | 18
Randomized Phase 2 [Member] |
Other Commitments [Line Items] |
Description of Clinical Trial | Doxorubicin with or without LB-100 in sarcoma
Estimated Start Date | July 2024
Estimated End Date | June 2026
Number of Patients in Trial | 150
Clinical Trial Phase 1b 2 [Member] |
Other Commitments [Line Items] |
Description of Clinical Trial | LB-100 combined with dostarlimab in ovarian clear cell carcinoma
Estimated Start Date | March 2024
Estimated End Date | December 2025
Number of Patients in Trial | 21

X
- Definition Clinical trial description. + References No definition available. + Details
Name: | LIXT_ClinicalTrialDescription
Namespace Prefix: | LIXT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contractual clinical trial period end date. + References No definition available. + Details
Name: | LIXT_ContractualClinicalTrialPeriodEndDate
Namespace Prefix: | LIXT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contractual clinical trial period start date. + References No definition available. + Details
Name: | LIXT_ContractualClinicalTrialPeriodStartDate
Namespace Prefix: | LIXT_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of patient in trial. + References No definition available. + Details
Name: | LIXT_NumberOfPatientInTrial
Namespace Prefix: | LIXT_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_OtherCommitmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhase1bMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhase1bTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialRandomizedPhaseTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhase1b2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |